Discontinued — last reported Q2 '23

Business Segments · Operating Income (Loss)

Consumer — Operating Income (Loss)

Johnson & Johnson Consumer — Operating Income (Loss) increased by 10.8% to $860.00M in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $784.00M to $860.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2009
Last reportedQ2 2023
Rolls up toOperating Income

How to read this metric

Higher operating income indicates strong operational efficiency and pricing power within the segment.

Detailed definition

This represents the profit or loss generated by the Consumer Health segment after deducting operating expenses from reve...

Peer comparison

Standard segment-level profitability metric used to compare operational efficiency across peers.

Metric ID: jnj_segment_consumer_health_operating_income_loss

Historical Data

7 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23
Value$804.00M-$636.00M$686.00M$784.00M$809.00M$776.00M$860.00M
QoQ Change-179.1%+207.9%+14.3%+3.2%-4.1%+10.8%
YoY Change-2.5%+227.2%+13.1%+9.7%
Range-$636.00M$860.00M
CAGR+4.6%
Avg YoY Growth+61.9%
Median YoY Growth+11.4%

Frequently Asked Questions

What is Johnson & Johnson's consumer — operating income (loss)?
Johnson & Johnson (JNJ) reported consumer — operating income (loss) of $860.00M in Q2 2023.
How has Johnson & Johnson's consumer — operating income (loss) changed year-over-year?
Johnson & Johnson's consumer — operating income (loss) increased by 9.7% year-over-year, from $784.00M to $860.00M.
What does consumer — operating income (loss) mean?
The operating profit or loss generated by the Consumer Health segment.